Dermographic urticaria induced by long-pulsed diode laser-assisted epilation: Rare etiology of a common eruption

Panth, Aanchal; Singh, Suvir; Khanna, Neena

doi:10.4103/2229-5178.202284

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are also rare factors such as long-pulsed diode laser-assisted epilation, N95 respirator, and COVID-19 vaccine booster that can cause dermographism (Table 2). 7,[37][38][39][40][41][42][43][44][45][46] Clinical manifestation of dermographism Dermographism is the most common subtype of Chronic Inducible Urticaria (CIndU) and coexists with other types of urticaria. SD is the most common subtype associated with CSU.…”

Section: Pathogenesis Of Dermographismmentioning

confidence: 99%

See 1 more Smart Citation

Shedding light on dermographism: a narrative review

Zhang,

Peng,

2024

Int J Dermatology

View full text Add to dashboard Cite

Dermographism is a common subtype of chronic urticaria. It generally manifests as a linear wheal after scratching or friction, with or without angioedema. The pathophysiology is not clear, but currently, we believe that the stimulation of the skin by mechanical stress leads to the activation of mast cells, which provoke the release of histamine and pro‐inflammatory mediators, ultimately forming wheal along the stressed area. The gold standard for diagnosis is a medical history and provocation test or dermatographic test. As one of the subtypes of chronic urticaria, the Urticaria Control Test (UCT), Chronic Urticaria Quality of Life questionnaire (CU‐Q2oL), and Dermatology Life Quality Index (DLQI) are also effective tools for evaluating disease control in dermographism patients. In addition to avoiding triggers, nonsedating H1 antihistamines are the first‐line medications recommended by EAACI and other guidelines; for those who do not respond to standard doses, the recommended dosage can be increased up to 4 times. When necessary, the off‐label use of omalizumab can be considered, and some drugs with potential therapeutic effects are still being explored. However, there is still a lack of biomarkers for predicting disease severity, efficacy, and prognosis. Here, we review what we know about dermographism and some points that need exploration in the future.

show abstract

Section: Pathogenesis Of Dermographismmentioning

confidence: 99%

“…There are also rare factors such as long‐pulsed diode laser‐assisted epilation, N95 respirator, and COVID‐19 vaccine booster that can cause dermographism (Table 2). 7,37–46 …”

Section: Pathogenesis Of Dermographismmentioning

confidence: 99%